CD28 and nasopharyngeal carcinoma: Our findings demonstrated higher levels of CD8 + cells, CD28 + CD8 + cells, and activated CD8 + cells in patients with LA-NPC 1 year after adjuvant metronomic capecitabine treatment compared to those in the control group.